SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
Xiaoxin X. Wang(Beijing Obstetrics and Gynecology Hospital), Moshe Levi(University of Colorado Anschutz Medical Campus), Almut Grenz(University of Colorado Anschutz Medical Campus), Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Jonathan Levi(National Institutes of Health), Yuhuan Luo(University of Colorado Anschutz Medical Campus), Evgenia Dobrinskikh(University of Colorado Anschutz Medical Campus), Michal Herman‐Edelstein(Rabin Medical Center), Hermann Koepsell(University of Würzburg), Yingqiong Peng(University of Colorado Anschutz Medical Campus), Dong Wang(University of Colorado Anschutz Medical Campus), Scott Lucia(University of Colorado Anschutz Medical Campus), Liru Qiu(University of Colorado Anschutz Medical Campus), Komuraiah Myakala(Georgetown University), Vivette D. D’Agati(Columbia University), Avi Z. Rosenberg(Johns Hopkins University)
Cited by 302
Related Papers
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
|Kidney International|2018|1k
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
|Nature Genetics|2008|706
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
|Journal of Lipid Research|2013|627
Glucose transporters in brain in health and disease
|Pflügers Archiv - European Journal of Physiology|2020|520